<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">53Rz7t3gCZ6HpTbpnjxtmFt</article-id>
      <article-id pub-id-type="other">00009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011001100009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09700209</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000076</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Compara&#231;&#227;o e correla&#231;&#227;o entre automedida, medida casual e monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Weimar Kunz Sebba Barroso de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jardim</surname>
            <given-names>Paulo C&#233;sar Brand&#227;o Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porto</surname>
            <given-names>Ludmila Brito</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#250;jo</surname>
            <given-names>Fabr&#237;cio Alves</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sousa</surname>
            <given-names>Ana Lu&#237;za Lima</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salgado</surname>
            <given-names>Cl&#225;udia Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Goi&#226;nia</named-content>
          <named-content content-type="state">Goi&#225;s</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Goi&#225;s</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Liga de Hipertens&#227;o Arterial</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>08</month>
        <year>2011</year>
      </pub-date>
      <volume>97</volume>
      <issue>2</issue>
      <fpage>148</fpage>
      <lpage>155</lpage>
      <history>
        <date date-type="accepted">
          <day>11</day>
          <month>04</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>08</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>03</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A medida casual da press&#227;o arterial (PA) pelos profissionais de sa&#250;de est&#225; sujeita a uma grande variabilidade, sendo necess&#225;rio buscar novos m&#233;todos que possam superar essa limita&#231;&#227;o. OBJETIVO: Comparar e avaliar a correla&#231;&#227;o entre os n&#237;veis de PA obtidos por meio da automedida da press&#227;o arterial (AMPA) com a medida casual e com a monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial (MAPA). M&#201;TODOS: Avaliamos hipertensos que realizaram as tr&#234;s metodologias de medida da PA com intervalo menor que 30 dias; as m&#233;dias das press&#245;es foram utilizadas para compara&#231;&#227;o e correla&#231;&#227;o. Foram empregados os aparelhos: OMRON 705 CP (medida casual), OMRON HEM 714 (AMPA) e SPACELABS 9002 (MAPA). RESULTADOS: Foram avaliados 32 pacientes, 50,09% mulheres, idade m&#233;dia 59,7 (&#177; 11,2) anos, m&#233;dia do IMC 26,04 (&#177; 3,3) kg/m&#178;. Valores m&#233;dios de press&#227;o sist&#243;lica (PAS) e press&#227;o diast&#243;lica (PAD) para a AMPA foram de 134 (&#177; 15,71)mmHg e 79,32 (&#177; 12,38) mmHg. Na medida casual as m&#233;dias da PAS e PAD foram, respectivamente, 140,84 (&#177; 16,15)mmHg e 85 (&#177; 9,68) mmHg. Os valores m&#233;dios da MAPA na vig&#237;lia foram 130,47 (&#177; 13,26) mmHg e 79,84 (&#177; 9,82) mmHg para PAS e PAD, respectivamente. Na an&#225;lise comparativa, a AMPA apresentou valores semelhantes aos da MAPA (p &gt; 0,05) e diferentes da medida casual (p &lt; 0,05). Na an&#225;lise de correla&#231;&#227;o a AMPA foi superior &#224; medida casual, considerando a MAPA como o padr&#227;o de refer&#234;ncia nas medidas tensionais. CONCLUS&#195;O: A AMPA apresentou melhor compara&#231;&#227;o com a MAPA do que a medida casual e tamb&#233;m se correlacionou melhor com a aquela, especialmente para a press&#227;o diast&#243;lica, devendo ser considerada uma alternativa com baixo custo para o acompanhamento do paciente hipertenso.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Hipertens&#227;o</kwd>
        <kwd>press&#227;o arterial</kwd>
        <kwd>monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial</kwd>
        <kwd>autocuidado</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>17</day>
        <month>06</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Compara&#231;&#227;o e correla&#231;&#227;o entre automedida, medida casual e monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial</bold>
    </p>
    <p>
      <bold>Weimar Kunz Sebba Barroso de Souza; Paulo C&#233;sar Brand&#227;o Veiga Jardim; Ludmila Brito Porto; Fabr&#237;cio Alves Ara&#250;jo; Ana Lu&#237;za Lima Sousa; Cl&#225;udia Maria Salgado</bold>
    </p>
    <p>Liga de Hipertens&#227;o Arterial, Faculdade de Medicina, Universidade Federal de Goi&#225;s, Goi&#226;nia, GO - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="ab1">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A medida casual da press&#227;o arterial (PA) pelos profissionais de sa&#250;de est&#225; sujeita a uma grande variabilidade, sendo necess&#225;rio buscar novos m&#233;todos que possam superar essa limita&#231;&#227;o. </p>
    <p><bold>OBJETIVO:</bold> Comparar e avaliar a correla&#231;&#227;o entre os n&#237;veis de PA obtidos por meio da automedida da press&#227;o arterial (AMPA) com a medida casual e com a monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial (MAPA). </p>
    <p><bold>M&#201;TODOS:</bold> Avaliamos hipertensos que realizaram as tr&#234;s metodologias de medida da PA com intervalo menor que 30 dias; as m&#233;dias das press&#245;es foram utilizadas para compara&#231;&#227;o e correla&#231;&#227;o. Foram empregados os aparelhos: OMRON 705 CP (medida casual), OMRON HEM 714 (AMPA) e SPACELABS 9002 (MAPA). </p>
    <p><bold>RESULTADOS:</bold> Foram avaliados 32 pacientes, 50,09% mulheres, idade m&#233;dia 59,7 (&#177; 11,2) anos, m&#233;dia do IMC 26,04 (&#177; 3,3) kg/m<sup>2</sup>. Valores m&#233;dios de press&#227;o sist&#243;lica (PAS) e press&#227;o diast&#243;lica (PAD) para a AMPA foram de 134 (&#177; 15,71)mmHg e 79,32 (&#177; 12,38) mmHg. Na medida casual as m&#233;dias da PAS e PAD foram, respectivamente, 140,84 (&#177; 16,15)mmHg e 85 (&#177; 9,68) mmHg. Os valores m&#233;dios da MAPA na vig&#237;lia foram 130,47 (&#177; 13,26) mmHg e 79,84 (&#177; 9,82) mmHg para PAS e PAD, respectivamente. Na an&#225;lise comparativa, a AMPA apresentou valores semelhantes aos da MAPA (p &gt; 0,05) e diferentes da medida casual (p &lt; 0,05). Na an&#225;lise de correla&#231;&#227;o a AMPA foi superior &#224; medida casual, considerando a MAPA como o padr&#227;o de refer&#234;ncia nas medidas tensionais. </p>
    <p><bold>CONCLUS&#195;O:</bold> A AMPA apresentou melhor compara&#231;&#227;o com a MAPA do que a medida casual e tamb&#233;m se correlacionou melhor com a aquela, especialmente para a press&#227;o diast&#243;lica, devendo ser considerada uma alternativa com baixo custo para o acompanhamento do paciente hipertenso.</p>
    <p><bold>Palavras-chave:</bold> Hipertens&#227;o, press&#227;o arterial, monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial, autocuidado.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A hipertens&#227;o arterial &#233; um importante fator de risco para doen&#231;as cardiovasculares e contribui direta e indiretamente para a elevada morbimortalidade tanto em pa&#237;ses desenvolvidos quanto em pa&#237;ses em desenvolvimento<sup>1,2</sup>. Nesse contexto, a determina&#231;&#227;o precisa dos n&#237;veis press&#243;ricos &#233; fundamental para a estratifica&#231;&#227;o do risco e a defini&#231;&#227;o da estrat&#233;gia terap&#234;utica adequada, sendo importante buscar op&#231;&#245;es para a grande variabilidade da press&#227;o arterial na vig&#234;ncia de fatores estressantes, por exemplo, durante uma consulta com o profissional de sa&#250;de<sup>3,4</sup>.</p>
    <p>A medida indireta da PA em consult&#243;rio (medida casual) &#233; considerada o procedimento padr&#227;o para o diagn&#243;stico e seguimento de pacientes hipertensos com valor preditivo para morbidade e mortalidade cardiovascular. Entretanto, se comparada aos m&#233;todos de monitoriza&#231;&#227;o da PA, &#233; inferior. A explica&#231;&#227;o para esse fato est&#225; nas limita&#231;&#245;es da medida casual que v&#227;o desde a influ&#234;ncia do observador (vieses de aferi&#231;&#227;o, efeito do jaleco branco) at&#233; o ambiente onde &#233; realizada e do n&#250;mero reduzido de leituras com baixa reprodutibilidade em longo prazo<sup>5-8</sup>.</p>
    <p>Dentre os m&#233;todos de monitoriza&#231;&#227;o, destaca-se a monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial (MAPA) como o padr&#227;o de refer&#234;ncia, permitindo a avalia&#231;&#227;o da PA durante as atividades habituais na vig&#237;lia e durante o sono, e, dessa maneira, possibilitando a realiza&#231;&#227;o de um maior n&#250;mero de medidas, o conhecimento da variabilidade e do descenso da PA durante o sono. A monitoriza&#231;&#227;o residencial da press&#227;o arterial (MRPA) &#233; outro m&#233;todo reconhecido e se caracteriza por contar com protocolos bem estabelecidos (certo n&#250;mero de medidas da PA pela manh&#227; e &#224; noite), tendo como vantagem a realiza&#231;&#227;o de um maior n&#250;mero de medidas fora do ambiente do consult&#243;rio e a boa aceitabilidade pelo paciente<sup>9</sup>. Estudos indicam que as m&#233;dias da press&#227;o arterial obtidas por MAPA e MRPA s&#227;o menores do que as obtidas por medida casual, t&#234;m maior acur&#225;cia no diagn&#243;stico e melhor predi&#231;&#227;o de risco cardiovascular, por&#233;m s&#227;o m&#233;todos caros e pouco acess&#237;veis aos nossos hipertensos<sup>10-12</sup>.</p>
    <p>Discute-se ainda uma terceira metodologia de monitoriza&#231;&#227;o, que &#233; a automedida da press&#227;o arterial (AMPA), o objetivo deste estudo. Sobre esse m&#233;todo existem poucas publica&#231;&#245;es at&#233; o momento. Sua caracter&#237;stica &#233; a aus&#234;ncia de protocolos preestabelecidos, o pr&#243;prio paciente realiza as medidas em seu domic&#237;lio, de maneira aleat&#243;ria, em aparelhos digitais autom&#225;ticos ou semiautom&#225;ticos validados. Tem como vantagens o baixo custo, a facilidade de manuseio e a possibilidade de evitar erros de leitura<sup>13,14</sup>. Justifica-se assim a realiza&#231;&#227;o deste estudo para avaliar a PA obtida pela AMPA, comparada &#224; medida casual e MAPA, visto que esse m&#233;todo poder&#225; constituir num futuro pr&#243;ximo uma alternativa de baixo custo e vi&#225;vel para a monitoriza&#231;&#227;o do hipertenso.</p>
    <p>
      <bold>Objetivos</bold>
    </p>
    <p>Comparar e correlacionar os n&#237;veis de press&#227;o arterial obtidos por meio de AMPA com a medida casual em consult&#243;rio e com a MAPA.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>O projeto de pesquisa n&#250;mero 144/07 foi avaliado e aprovado pelo Comit&#234; de &#201;tica em Pesquisa M&#233;dica Humana e Animal do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade Federal de Goi&#225;s (UFG). Os participantes foram informados sobre os procedimentos do estudo e assinaram o termo de consentimento livre e esclarecido.</p>
    <p>Trata-se de estudo prospectivo com amostra constitu&#237;da por pacientes em acompanhamento na Liga de Hipertens&#227;o Arterial convidados a realizar a medida casual, MAPA e AMPA, com intervalo menor que 30 dias entre os m&#233;todos (n = 32).</p>
    <p>O crit&#233;rios de inclus&#227;o envolveu adultos de ambos os sexos (maiores de 18 e menores de 70 anos), portadores de hipertens&#227;o arterial sob tratamento medicamentoso, em seguimento regular &#224;s consultas agendadas (o crit&#233;rio de ades&#227;o foi o comparecimento a todas as consultas no ano anterior). Os crit&#233;rios de exclus&#227;o contemplaram impossibilidade ou nega&#231;&#227;o para assinar o termo de consentimento, participa&#231;&#227;o em outros protocolos de pesquisa, portadores de doen&#231;as cr&#244;nicas em est&#225;gios terminais, portadores de hipertens&#227;o est&#225;gio III<sup>8</sup> ou hipertens&#227;o resistente, obesidade (IMC &gt; 30 kg/m<sup>2</sup>), arritmia card&#237;aca, hist&#243;ria de eventos cardiocirculat&#243;rios nos &#250;ltimos seis meses (infarto agudo do mioc&#225;rdio, acidente vascular cerebral, acidente isqu&#234;mico transit&#243;rio), insufici&#234;ncia renal cr&#244;nica, insufici&#234;ncia card&#237;aca descompensada, diabete descompensada, outras doen&#231;as que no julgamento do investigador pudessem comprometer o estudo, hipertens&#227;o secund&#225;ria e terapia de reposi&#231;&#227;o hormonal que n&#227;o estivesse em dose est&#225;vel h&#225; pelo menos seis meses.</p>
    <p>Os par&#226;metros antropom&#233;tricos foram avaliados como se segue:</p>
    <p><italic>Massa corporal</italic> - Indiv&#237;duos vestidos com roupas leves e sem cal&#231;ados, com utiliza&#231;&#227;o de balan&#231;a eletr&#244;nica da marca Toledo com precis&#227;o de 100 g.</p>
    <p><italic>Altura</italic> - Indiv&#237;duos descal&#231;os utilizando estadi&#244;metro da marca Filizola com precis&#227;o de um mil&#237;metro.</p>
    <p><italic>&#205;ndice de massa corp&#243;rea (IMC)</italic> - Mediante a f&#243;rmula estabelecida por QUETELET (IMC = Peso em kg/Altura<sup>2</sup> em metro).</p>
    <p>As metodologias empregadas na medida da press&#227;o arterial foram:</p>
    <disp-quote>
      <p><italic>&#149; Medida casual em consult&#243;rio</italic> - Realizada de acordo com as t&#233;cnicas recomendadas pelas VI DBHA, 2010<sup>8</sup>. A PA foi aferida com esfigmoman&#244;metro autom&#225;tico digital (OMRON 705 CP) com o paciente na posi&#231;&#227;o sentada, ap&#243;s 10 minutos de repouso, o bra&#231;o apoiado e na altura do prec&#243;rdio. Foram realizadas duas medidas no per&#237;odo matinal, sempre pelo mesmo observador, com intervalo de dois minutos entre elas,considerada a m&#233;dia para efeito de an&#225;lise.</p>
      <p><italic>&#149; Automedida</italic> - Os pacientes receberam no in&#237;cio do estudo um aparelho semiautom&#225;tico HEM 714 da marca OMRON para a automedida sistem&#225;tica da press&#227;o arterial, sendo estabelecido que a medida deveria ser feita no per&#237;odo matutino entre 8h e 10h, ou no per&#237;odo vespertino entre 18h e 20h, durante, no m&#237;nimo, dois dias da semana. Medidas adicionais puderam ser realizadas a crit&#233;rio dos pacientes, mas n&#227;o foram utilizadas para o c&#225;lculo da m&#233;dia. O treinamento para o uso do aparelho de acordo com as orienta&#231;&#245;es da VI DBHA foi realizado pelos autores deste protocolo. Para o c&#225;lculo da m&#233;dia consideramos oito medidas consecutivas (um m&#234;s) &#224; consulta m&#233;dica do paciente.</p>
      <p><italic>&#149; MAPA</italic> - Realizada com o Monitor Spacelabs 9002, sendo padronizadas medidas a cada 15 minutos no per&#237;odo de vig&#237;lia, e a cada 20 minutos no per&#237;odo de sono. Os dados foram considerados v&#225;lidos quando a monitoriza&#231;&#227;o aconteceu por um per&#237;odo m&#237;nimo de 21h com um n&#250;mero m&#237;nimo de 16 medidas na vig&#237;lia e oito medidas durante o sono. O paciente foi orientado a fazer um di&#225;rio e anotar, no dia do exame, todas as atividades realizadas no per&#237;odo e os hor&#225;rios de tomada de medica&#231;&#227;o<sup>9</sup>. Ao retirar a MAPA, foi feita a impress&#227;o do relat&#243;rio, encaminhado para laudo m&#233;dico. Esse foi arquivado juntamente com o relat&#243;rio impresso no prontu&#225;rio do paciente. Para o c&#225;lculo das m&#233;dias das 24 horas, foram consideradas todas as medidas obtidas; para o c&#225;lculo das m&#233;dias de vig&#237;lia foram consideradas as medidas realizadas no per&#237;odo das 7h &#224;s 23h, e para o c&#225;lculo das m&#233;dias de sono foram consideradas as medidas obtidas das 23h &#224;s 7h.</p>
    </disp-quote>
    <p>Os dados foram armazenados e estruturados no programa Excel Microsoft. A an&#225;lise estat&#237;stica foi realizada por meio do <italic>software</italic> SPSS (<italic>Statistical Package of Social Science</italic>) para Windows vers&#227;o 15.0. O teste de Kolmogorov-Smirnov foi utilizado para analisar se vari&#225;veis num&#233;ricas apresentavam distribui&#231;&#227;o normal. O teste <italic>t</italic> para amostra pareadas foi utilizado para comparar m&#233;dias, vari&#225;veis num&#233;ricas, e a correla&#231;&#227;o de Pearson, para avaliar a correla&#231;&#227;o entre a PA da automedida com a MAPA e a medida casual de consult&#243;rio.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Foram avaliados 32 pacientes: 50,09% eram do sexo feminino e a m&#233;dia de idade foi de 59,7 (&#177; 11,2) anos. A m&#233;dia do IMC foi de 26,04 (&#177; 3,3) kg/m<sup>2</sup>.</p>
    <p>Os valores m&#233;dios de press&#227;o sist&#243;lica (PAS) e press&#227;o diast&#243;lica (PAD) encontrados pela automedida foram de 134,00 (&#177; 15,71) mmHg e 79,32 (&#177; 12,38) mmHg, respectivamente. Na medida casual, a m&#233;dia da PAS foi 140,84 (&#177; 16,15) mmHg, e da PAD foi 85,00 (&#177; 9,68) mmHg. A m&#233;dia das medidas pela MAPA na vig&#237;lia foi de 130,47(&#177; 13,26) mmHg e 79,84 (&#177; 9,82) mmHg para PAS e PAD respectivamente (<xref ref-type="table" rid="tab1">tab. 1</xref> e <xref ref-type="table" rid="tab2">2</xref>).</p>
    <table-wrap id="tab1">
      <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gt01.jpg"/></table-wrap>
    <table-wrap id="tab2">
      <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gt02.jpg"/></table-wrap>
    <p>Ao realizarmos a compara&#231;&#227;o entre as m&#233;dias das press&#245;es encontramos diferen&#231;as significativas nas m&#233;dias press&#243;ricas entre AMPA e medida casual, tanto para a PAS (p = 0,031) quanto para a PAD (p = 0,003) (<xref ref-type="table" rid="tab1">tab. 1</xref>). Mas na compara&#231;&#227;o da AMPA com a MAPA na vig&#237;lia n&#227;o observamos diferen&#231;a entre as m&#233;dias das PAS e PAD (p = 0,064 e p = 0,719) (<xref ref-type="table" rid="tab2">tab. 2</xref>).</p>
    <p>Encontramos correla&#231;&#227;o significativa entre a AMPA e a PA casual tanto para PAS quanto para PAD (p &lt; 0,017 e p &lt; 0,000, respectivamente), assim como entre a AMPA e a MAPA de vig&#237;lia (p &lt; 0,000 para PAS e PAD) Por&#233;m, a correla&#231;&#227;o foi melhor entre os valores obtidos pela AMPA com os da MAPA de vig&#237;lia tanto para PAS e PAD (r = 0,755 e 0,753) em compara&#231;&#227;o com os observados nas medidas pela AMPA e medida casual para PAS e PAD, respectivamente (r = 0,419 e r = 0,609). N&#227;o foi observada correla&#231;&#227;o entre os valores da PAS obtidos pela medida casual com os da MAPA durante a vig&#237;lia (p = 0,227), havendo correla&#231;&#227;o significativa apenas com a PAD nesse caso (p &lt; 0,000) (<xref ref-type="fig" rid="aop06811fig01">fig. 1</xref>, <xref ref-type="fig" rid="aop06811fig02">2</xref> e <xref ref-type="fig" rid="aop06811fig03">3</xref>).</p>
    <p content-type="asset">
      <fig id="aop06811fig01">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf01.jpg"/></fig>
    </p>
    <p content-type="asset">
      <fig id="aop06811fig02">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf02.jpg"/></fig>
    </p>
    <p content-type="asset">
      <fig id="aop06811fig03">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf03.jpg"/></fig>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>A medida casual da press&#227;o arterial tem sido o pilar do diagn&#243;stico e acompanhamento do paciente hipertenso h&#225; mais de cem anos. Entretanto, &#233; preciso encarar as limita&#231;&#245;es e fragilidades dessa metodologia, levando em considera&#231;&#227;o a grande varia&#231;&#227;o que ocorre na PA ao longo do dia, as in&#250;meras interfer&#234;ncias que diversas situa&#231;&#245;es provocam nos seus valores e correlacionando esses fatos ao pequeno n&#250;mero de medidas que s&#227;o realizadas por esse m&#233;todo<sup>15,16</sup>.</p>
    <p>Uma s&#233;rie de outros fatores tamb&#233;m interfere nas medidas isoladas nos consult&#243;rios dos profissionais de sa&#250;de, e esses podem ser dependentes do operador, do paciente ou do aparelho, resultando em situa&#231;&#245;es que muitas vezes n&#227;o s&#227;o condizentes com os reais n&#237;veis da press&#227;o arterial do indiv&#237;duo<sup>17,18</sup>. Nesse contexto, a hipertens&#227;o mascarada n&#227;o ser&#225; diagnosticada se n&#227;o utilizarmos m&#233;todos que permitam a medida da PA fora do ambiente de consult&#243;rio, e esses pacientes que t&#234;m risco cardiovascular aumentado n&#227;o ser&#227;o tratados de maneira adequada<sup>19,20</sup>. No outro extremo, e pela mesma limita&#231;&#227;o do m&#233;todo, encontraremos os portadores de hipertens&#227;o do avental branco, que receber&#227;o medicamentos desnecessariamente<sup>21</sup>.</p>
    <p>A MAPA &#233; um m&#233;todo que permite maior precis&#227;o no diagn&#243;stico e seguimento dos pacientes<sup>4,14,15,17</sup>. Todavia, a realiza&#231;&#227;o dessa metodologia em todos os hipertensos seria muito onerosa e invi&#225;vel do ponto de vista de sa&#250;de p&#250;blica. As limita&#231;&#245;es aqui descritas indicam a necessidade de podermos contar com outras metodologias que permitam a medida da press&#227;o arterial fora do ambiente hospitalar ou ambulatorial, de baixo custo e confi&#225;veis, e que nos forne&#231;am os valores da PA sem a influ&#234;ncia do profissional de sa&#250;de como observador. Essas caracter&#237;sticas s&#227;o preenchidas pela AMPA.</p>
    <p>A automedida da press&#227;o arterial no modelo adotado neste estudo apresenta poucas publica&#231;&#245;es nos peri&#243;dicos nacionais e internacionais. Frequentemente o que &#233; encontrado na literatura &#233; a refer&#234;ncia ao termo AMPA (<italic>self measured blood pressure</italic> ou <italic>home blood pressure</italic>) como equivalente &#224; monitoriza&#231;&#227;o residencial da press&#227;o arterial com orienta&#231;&#245;es para o uso dos aparelhos de acordo com protocolos preestabelecidos. Na nossa amostra, os pacientes foram orientados para realizar um m&#237;nimo de duas medidas semanais da PA, havendo, por&#233;m, liberdade para que outras medidas pudessem ser realizadas. Corroborando a metodologia adotada neste estudo, recentemente a Sociedade Europeia de Hipertens&#227;o recomendou em suas diretrizes que, para acompanhamento em longo prazo de pacientes hipertensos, duas medidas semanais com aparelhos validados podem ser empregadas<sup>22</sup>.</p>
    <p>N&#227;o foi nosso objetivo analisar desfechos cardiovasculares, o que testamos foi a hip&#243;tese de que a medida da PA pelo paciente, em ambiente domiciliar, com aparelhos validados e sem protocolos preestabelecidos, teria melhor correla&#231;&#227;o e compara&#231;&#227;o com a MAPA do que a medida casual, hip&#243;tese que se confirmou. A quest&#227;o sobre a confiabilidade e reprodutibilidade da AMPA j&#225; foi testada anteriormente, mas com protocolos de medidas preestabelecidas e com resultados satisfat&#243;rios para esse tipo de an&#225;lise, at&#233; mesmo na predi&#231;&#227;o de desfechos cardiovasculares<sup>22-24</sup>.</p>
    <p>Os nossos resultados mostram que os valores de press&#227;o arterial na AMPA s&#227;o mais baixos do que os obtidos pela medida casual, e mais coincidentes com os encontrados na MAPA na vig&#237;lia. Al&#233;m disso, a AMPA apresenta boa correla&#231;&#227;o com as duas metodologias. Esses achados apontam para boas perspectivas desse m&#233;todo no seguimento de pacientes hipertensos, podendo atenuar diversos desvios de medidas que surgem quando utilizamos apenas a medida casual da press&#227;o arterial e permitindo que um n&#250;mero maior de indiv&#237;duos tenha acesso &#224; monitoriza&#231;&#227;o da sua PA<sup>25</sup>.</p>
    <p>Outra publica&#231;&#227;o demonstrou que a AMPA, al&#233;m de se comparar e correlacionar melhor com a MAPA do que a medida casual, tamb&#233;m &#233; melhor preditora de risco de hipertrofia ventricular esquerda em hipertensos<sup>22</sup>, o que refor&#231;a a sua utilidade na rotina de acompanhamento desses pacientes. Dessa maneira, a perspectiva da utiliza&#231;&#227;o desse m&#233;todo nos parece bastante atrativa, merecendo ser mais estudada com grandes possibilidades de ser incorporada como mais uma op&#231;&#227;o para o acompanhamento do paciente hipertenso.</p>
    <p>A superioridade das MAPA e MRPA em compara&#231;&#227;o com a medida casual da PA j&#225; foi demonstrada<sup>15,25</sup>, havendo, at&#233; mesmo, a recomenda&#231;&#227;o em diretrizes para a utiliza&#231;&#227;o mais frequente desses m&#233;todos<sup>26</sup>. Recentemente, alguns estudos inclu&#237;ram recomenda&#231;&#245;es para que a medida da PA fora do ambiente ambulatorial, realizada pelo paciente e com aparelhos validados, seja cada vez mais utilizada, entendendo haver tamb&#233;m nessa metodologia vantagens no seguimento e tratamento da hipertens&#227;o arterial<sup>9,17,22,27-29</sup>.</p>
    <p>Essa orienta&#231;&#227;o pode representar, num futuro muito pr&#243;ximo, uma mudan&#231;a no paradigma da medida e controle da press&#227;o arterial, pois o paciente passaria a ter um papel ativo e mais importante no conhecimento e acompanhamento dos seus n&#237;veis press&#243;ricos, quem sabe assim interferindo positivamente nas taxas de ades&#227;o e controle da PA.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Esses achados indicam a possibilidade de utiliza&#231;&#227;o da AMPA como um m&#233;todo alternativo de monitoriza&#231;&#227;o da press&#227;o na popula&#231;&#227;o hipertensa, com melhor compara&#231;&#227;o e correla&#231;&#227;o com a MAPA do que a medida casual.</p>
    <p>
      <bold>Limita&#231;&#245;es do estudo</bold>
    </p>
    <p>O n&#250;mero de pacientes avaliados neste estudo &#233; pequeno e outras an&#225;lises com uma amostragem maior se fazem necess&#225;rias. Apesar disso, a signific&#226;ncia estat&#237;stica tanto na an&#225;lise de compara&#231;&#227;o quanto de correla&#231;&#227;o nos faz pensar que as conclus&#245;es deste trabalho est&#227;o na dire&#231;&#227;o correta.</p>
    <p>
      <fn id="ab1" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Weimar Kunz Sebba Barroso de Souza </p>
        <p> Rua T-58, n&#186; 315, sala 109, setor Bueno </p>
        <p> 74223-130 - Goi&#226;nia, GO - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="weimarsb@cardiol.br">weimarsb@cardiol.br</email>, </p>
        <p>
          <email xlink:href="wsebba@uol.com.br">wsebba@uol.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 03/12/10; revisado recebido em 08/12/10; aprovado em 11/04/11.</p>
    <p>Full texts in English - <ext-link ext-link-type="uri" xlink:href="http://www.arquivosonline.com.br"><italic>http://www.arquivosonline.com.br</italic></ext-link></p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Stokes J, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a major risk factor for cardiovascular disease: the Framinghamn study. 30 years of follow-up. Hypertension. 1989;13(5 Suppl): I13-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blood pressure as a major risk factor for cardiovascular disease: the Framinghamn study. 30 years of follow-up</article-title>
          <source>Hypertension</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>I13</fpage>
          <lpage>8</lpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stokes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kannel</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>D'Agostino</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Cupples</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Mathers CD, Bernard C, Iburg KM, Innoue M, Fat DM, Shibuya K, et al. Global burden of disease in 2002: data sources, methods and results. Geneva: World Health Organization; 2003. (Global Programme on Evidence for Health Policy Discussion Paper n. 54).</mixed-citation>
        <element-citation publication-type="book">
          <source>Global burden of disease in 2002: data sources, methods and results</source>
          <date>
            <year>2003</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Mathers</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Iburg</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Innoue</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fat</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Shibuya</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA. 2003;289(19):2560-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report</article-title>
          <source>JAMA</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2560</fpage>
          <lpage>72</lpage>
          <issue>19</issue>
          <volume>289</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chobanian</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Bakris</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Izzo Jr</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurements. J Hypertens. 2005;23(4):697-701.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurements</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>697</fpage>
          <lpage>701</lpage>
          <issue>4</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beilin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Imai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mancia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mengden</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1):10-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hypertension treatment and control in five European countries, Canada, and the United States</article-title>
          <source>Hypertension</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>10</fpage>
          <lpage>7</lpage>
          <issue>1</issue>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wolf-Maier</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Banegas</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Giampaoli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Joffres</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Jardim PCBV, Monego ET, Reis MA, Souza ALL. Aspectos hist&#243;ricos e tend&#234;ncias atuais na medida da press&#227;o arterial. Rev Bras Hipertens. 2000;7(1):25-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aspectos hist&#243;ricos e tend&#234;ncias atuais na medida da press&#227;o arterial</article-title>
          <source>Rev Bras Hipertens</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>25</fpage>
          <lpage>30</lpage>
          <issue>1</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jardim</surname>
              <given-names>PCBV</given-names>
            </name>
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>ALL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Souza ALL, Monego ET. Manual de t&#233;cnicas: medidas da press&#227;o arterial e avalia&#231;&#227;o nutricional. Goi&#226;nia: CEGRAF; 1996.</mixed-citation>
        <element-citation publication-type="book">
          <source>Manual de t&#233;cnicas: medidas da press&#227;o arterial e avalia&#231;&#227;o nutricional</source>
          <date>
            <year>1996</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Souza</surname>
              <given-names>ALL</given-names>
            </name>
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. VI Diretrizes brasileiras de hipertensao arterial. Rev Bras Hipertens. 2010;17(1):1-64.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>VI Diretrizes brasileiras de hipertensao arterial</article-title>
          <source>Rev Bras Hipertens</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>1</fpage>
          <lpage>64</lpage>
          <issue>1</issue>
          <volume>17</volume>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Alessi A, Brand&#227;o AA, Pierin A, Feitosa AM, Machado CA, de Moraes Forjaz CL, et al. IV Diretriz para uso da monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial. II Diretriz para uso da monitoriza&#231;&#227;o residencial da press&#227;o arterial IV MAPA/II MRPA. Arq Bras Cardiol. 2005;85(supl 2):1-18.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretriz para uso da monitoriza&#231;&#227;o ambulatorial da press&#227;o arterial: II Diretriz para uso da monitoriza&#231;&#227;o residencial da press&#227;o arterial IV MAPA/II MRPA</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1</fpage>
          <lpage>18</lpage>
          <volume>85</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alessi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Pierin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Feitosa</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>de Moraes Forjaz</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Pickering TG, James GD. Ambulatory blood pressure and prognosis. J Hypertens Suppl. 1994;12(8):S29-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ambulatory blood pressure and prognosis</article-title>
          <source>J Hypertens Suppl</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>S29</fpage>
          <lpage>33</lpage>
          <issue>8</issue>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pickering</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793-801.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension</article-title>
          <source>Hypertension</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>793</fpage>
          <lpage>801</lpage>
          <issue>6</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Verdecchia</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Porcellati</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schillaci</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Borgioni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ciucci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Battistelli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Clement DL, De Buyzere ML, De Bacquer DA, Duprez DA, Fagard RH, Missault LH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2407</fpage>
          <lpage>15</lpage>
          <issue>24</issue>
          <volume>348</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Clement</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>De Buyzere</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>De Bacquer</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Duprez</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Fagard</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Missault</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Martin GM, Parati G. Self measure blood pressure in the office and at home. J Hypertens. 2003;21(12):2223-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Self measure blood pressure in the office and at home</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2223</fpage>
          <lpage>5</lpage>
          <issue>12</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Parati</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Verberk WJ, Kroon AA, Jongen-Bancraybex HA, De Leeuw PW. The applicability of home blood pressure measurement in clinical practice: a review of literature. Vasc Health Risk Manag. 2007;3(6):959-66.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The applicability of home blood pressure measurement in clinical practice: a review of literature</article-title>
          <source>Vasc Health Risk Manag</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>959</fpage>
          <lpage>66</lpage>
          <issue>6</issue>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Verberk</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Kroon</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Jongen-Bancraybex</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>De Leeuw</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Parati G, Stergiou GS, Asmar R, Belo G, de Leew P, Imui Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26(8):1505-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1505</fpage>
          <lpage>26</lpage>
          <issue>8</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Parati</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stergiou</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Belo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>de Leew</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Imui</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. O'Brien E. Ambulatory blood pressure measurement: the case for implementation in primary care. Hypertension. 2008;51(6):1435-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ambulatory blood pressure measurement: the case for implementation in primary care</article-title>
          <source>Hypertension</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1435</fpage>
          <lpage>41</lpage>
          <issue>6</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23(4):697-701.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>697</fpage>
          <lpage>701</lpage>
          <issue>4</issue>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beilin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Imai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mancia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mengden</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Stergiou G, Mengden T, Padfield PL, Parati G, O'Brien E. Self monitoring of blood pressure at home. BMJ. 2004;329(7471):870-1.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Self monitoring of blood pressure at home</article-title>
          <source>BMJ</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>870</fpage>
          <lpage>1</lpage>
          <issue>7471</issue>
          <volume>329</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stergiou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mengden</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Padfield</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Parati</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Fagard RH, Celis H. Prognostic significance of various characteristics of out-of-the-office blood pressure. J Hypertens. 2004;22(9):1663-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic significance of various characteristics of out-of-the-office blood pressure</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1663</fpage>
          <lpage>6</lpage>
          <issue>9</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fagard</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Celis</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Bobrie G, Clerson P, Menard J, Vinay NP, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26(9):1715-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Masked hypertension: a systematic review</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1715</fpage>
          <lpage>25</lpage>
          <issue>9</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bobrie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Clerson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Menard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vinay</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Chatellier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Plouin</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Banegas JR, Segura J, Sobrino J, Rodrigues-Artalejo F, De La Sierra A, De La Cruz JJ, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49(1):62-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effectiveness of blood pressure control outside the medical setting</article-title>
          <source>Hypertension</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>62</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Banegas</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Segura</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sobrino</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rodrigues-Artalejo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>De La Sierra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De La Cruz</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779-85.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>European Society of Hypertension practice guidelines for home blood pressure monitoring</article-title>
          <source>J Hum Hypertens</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>779</fpage>
          <lpage>85</lpage>
          <issue>12</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Parati</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stergiou</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bilo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>de Leeuw</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Imai</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Myers MG, Parati G. Self-measurement of blood pressure in the office and at home. J Hypertens. 2003;21(12):2223-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Self-measurement of blood pressure in the office and at home</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2223</fpage>
          <lpage>5</lpage>
          <issue>12</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Parati</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Oikawa T, Obara T, Okhubo T, Kikuya M, Asayama K, Metoki H, et al. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: The J-HOME study. J Hypertens. 2006;24(9):1737-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: The J-HOME study</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1737</fpage>
          <lpage>43</lpage>
          <issue>9</issue>
          <volume>24</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oikawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Obara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okhubo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kikuya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Asayama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Metoki</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T, Hoshi H, et al. Use of 2003 European Society of Hypertension - European Society of Cardiology Guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama Study. Eur Heart J. 2005;26(19): 2026-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Use of 2003 European Society of Hypertension - European Society of Cardiology Guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama Study</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2026</fpage>
          <lpage>31</lpage>
          <issue>19</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Asayama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohkubo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kikuya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Metoki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Obara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hoshi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Staessen JA, Thijs L, Ohkubo T, Kikuya M, Richart T, Boggia J, et al. Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit. 2008;13(6):352-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home</article-title>
          <source>Blood Press Monit</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>352</fpage>
          <lpage>65</lpage>
          <issue>6</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Staessen</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Thijs</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ohkubo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kikuya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Richart</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Boggia</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Asmar R, Zanchetti A. Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference Groupe Evaluation and Measurement of the French Society of Hypertension. J Hypertens. 2000;18(5):493-508.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference Groupe Evaluation and Measurement of the French Society of Hypertension</article-title>
          <source>J Hypertens</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>493</fpage>
          <lpage>508</lpage>
          <issue>5</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Asmar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zanchetti</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Coca A, Bertomeu V, Dalf&#243; A, Esmatjes E, Guillen F, Guerrero L, et al. [Blood pressure self measurement: Spanish consensus document]. Nefrologia. 2007;27(2):139-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blood pressure self measurement: Spanish consensus document</article-title>
          <source>Nefrologia</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>139</fpage>
          <lpage>53</lpage>
          <issue>2</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Coca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bertomeu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dalf&#243;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Esmatjes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guillen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Guerrero</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Maldonado J, Pereira T, Estudo AMPA. Auto-medi&#231;&#227;o da press&#227;o arterial - an&#225;lise preliminar do Estudo AMPA. Rev Port Cardiol. 2009;28(1):7-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Auto-medi&#231;&#227;o da press&#227;o arterial - an&#225;lise preliminar do Estudo AMPA</article-title>
          <source>Rev Port Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>7</fpage>
          <lpage>21</lpage>
          <issue>1</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maldonado</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Estudo</surname>
              <given-names>AMPA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Comparison and correlation between self-measured blood pressure, casual blood pressure measurement and ambulatory blood pressure monitoring</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Casual blood pressure (BP) measurement by healthcare professionals is subject to great variability and new methods are necessary to overcome this limitation. OBJECTIVE: To compare and assess the correlation between the BP levels obtained by self-measured BP (SMBP), casual BP measurement and ambulatory blood pressure monitoring (ABPM). METHODS: We assessed hypertensive individuals submitted to the three methods of BP measurement at an interval &lt; 30 days; the BP means were used for comparison and correlation. The following devices were used: OMRON 705 CP (casual measurement), OMRON HEM 714 (SMBP) and SPACELABS 9002 (ABPM). RESULTS: A total of 32 patients were assessed, of which 50.09% were females, with a mean age of 59.7 (&#177; 11.2), BMI mean of 26.04 (&#177; 3.3) kg/m&#178;. Mean systolic (SBP) and diastolic blood pressure (DBP) for SMBP were 134 (&#177; 15.71) mmHg and 79.32 (&#177; 12.38) mmHg. The casual measurement means of SBP and DBP were, respectively, 140.84 (&#177; 16.15) mmHg and 85 (&#177; 9.68) mmHg. The mean values of ABPM during the wakefulness period were 130.47 (&#177; 13.26) mmHg and 79.84 (&#177; 9.82) mmHg for SBP and DBP, respectively. At the comparative analysis, the SMBP had similar results to those obtained at ABPM (p &gt; 0.05) and different from the casual measurement (p &lt; 0.05). At the analysis of correlation, SMBP values were higher than the casual measurements, considering ABPM as the reference standard in BP measurements. CONCLUSION: SMBP showed a better correlation with ABPM than the casual measurement and was also better correlated with the latter, especially regarding the DBP and should be considered as a low-cost alternative for the follow-up of the hypertensive patient.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Hypertension</kwd>
        <kwd>blood pressure</kwd>
        <kwd>blood pressure monitoring, ambulatory</kwd>
        <kwd>self-care</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <fn id="ab-body2">
          <label>
            <bold>Comparison and correlation between self-measured blood pressure, casual blood pressure measurement and ambulatory blood pressure monitoring</bold>
          </label>
          <p>
            <bold>Weimar Kunz Sebba Barroso de Souza; Paulo C&#233;sar Brand&#227;o Veiga Jardim; Ludmila Brito Porto; Fabr&#237;cio Alves Ara&#250;jo; Ana Lu&#237;za Lima Sousa; Cl&#225;udia Maria Salgado</bold>
          </p>
        </fn>
      </p>
      <p>Liga de Hipertens&#227;o Arterial, Faculdade de Medicina, Universidade Federal de Goi&#225;s, Goi&#226;nia, GO - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Casual blood pressure (BP) measurement by healthcare professionals is subject to great variability and new methods are necessary to overcome this limitation.</p>
      <p><bold>OBJECTIVE:</bold> To compare and assess the correlation between the BP levels obtained by self-measured BP (SMBP), casual BP measurement and ambulatory blood pressure monitoring (ABPM).</p>
      <p><bold>METHODS:</bold> We assessed hypertensive individuals submitted to the three methods of BP measurement at an interval &lt; 30 days; the BP means were used for comparison and correlation. The following devices were used: OMRON 705 CP (casual measurement), OMRON HEM 714 (SMBP) and SPACELABS 9002 (ABPM).</p>
      <p><bold>RESULTS:</bold> A total of 32 patients were assessed, of which 50.09% were females, with a mean age of 59.7 (&#177; 11.2), BMI mean of 26.04 (&#177; 3.3) kg/m<sup>2</sup>. Mean systolic (SBP) and diastolic blood pressure (DBP) for SMBP were 134 (&#177; 15.71) mmHg and 79.32 (&#177; 12.38) mmHg. The casual measurement means of SBP and DBP were, respectively, 140.84 (&#177; 16.15) mmHg and 85 (&#177; 9.68) mmHg. The mean values of ABPM during the wakefulness period were 130.47 (&#177; 13.26) mmHg and 79.84 (&#177; 9.82) mmHg for SBP and DBP, respectively. At the comparative analysis, the SMBP had similar results to those obtained at ABPM (p &gt; 0.05) and different from the casual measurement (p &lt; 0.05). At the analysis of correlation, SMBP values were higher than the casual measurements, considering ABPM as the reference standard in BP measurements.</p>
      <p><bold>CONCLUSION:</bold> SMBP showed a better correlation with ABPM than the casual measurement and was also better correlated with the latter, especially regarding the DBP and should be considered as a low-cost alternative for the follow-up of the hypertensive patient.</p>
      <p><bold>Keywords:</bold> Hypertension; blood pressure; blood pressure monitoring, ambulatory, self-care.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Arterial hypertension is an important risk factor for cardiovascular diseases and directly and indirectly contributes to the high morbimortality in both developed and developing countries<sup>1,2</sup>. In this context, the accurate measurement of blood pressure (BP) levels is of utmost importance for risk stratification and to define the adequate therapeutic strategy, being important to seek alternatives for the great variability of BP in the presence of stress factors , such as for instance, during a consultation with the healthcare professional<sup>3,4</sup>.</p>
      <p>The indirect measurement of BP at the medical office (casual measurement) is considered the standard procedure for the diagnosis and follow-up of hypertensive patients with predictive value for cardiovascular morbidity and mortality. However, when compared with the BP monitoring methods, it is considered inferior. That fact can be explained by the limitations of the casual measurement, which include from the examiner's influence (measurement bias, white-coat effect) to the environment where the measurement is carried out and the reduced number of readings with low reproducibility in the long term<sup>5-8</sup>.</p>
      <p>Among the monitoring methods, the ambulatory blood pressure monitoring (ABPM) is considered the reference standard, allowing the assessment of BP during daily routine activities in the wakefulness period and during sleep, therefore allowing a larger number of readings to be obtained, as well as the knowledge of the BP variability and nocturnal dipping during sleep. The home blood pressure monitoring (HBPM) is another acknowledged method, characterized by having well-established protocols (certain number of BP readings in the morning and at night), having the advantage of yielding a higher number of readings outside the medical office environment and good patient adherence<sup>9</sup>. Studies indicate that BP means obtained by ABPM and HBPM are lower than those obtained at casual measurements, are more accurate in the diagnosis and better predict cardiovascular risk; however, these are expensive and little accessible methods for our hypertensive patients<sup>10-12</sup>.</p>
      <p>A third method of BP monitoring, the self-measured blood pressure (SMBP), is the objective of the present study. There have been few publications on this method to date. Its characteristic is the absence of pre-established protocols - the patient him- or herself performs random measurements at home, in validated automatic or semiautomatic digital blood pressure devices for home use. This is a low-cost, easy-to-use method and there is the possibility of preventing reading error<sup>13,14</sup>, thus justifying carrying out this study to assess BP measurements obtained at SMBP and compare them with casual measurements and ABPM, considering that this method might constitute in a near future, a low-cost and feasible method to monitor hypertensive patients.</p>
      <p>
        <bold>Objectives</bold>
      </p>
      <p>To compare e correlate BP levels obtained by SMBP with casual measurements and ABPM.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>Research project #144/07 was evaluated and approved by the Ethics Committee in Human and Animal Medical Research of <italic>Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade Federal de Goi&#225;s</italic> (UFG). The participants were informed on the study procedures and signed the Free and Informed Consent Form.</p>
      <p>The present is the prospective study of a sample consisting of patients being followed at the Arterial Hypertension League, who were invited to undergo casual BP measurements, ABPM and SMBP, with an interval &lt; 30 days between the methods (n = 32).</p>
      <p>Inclusion criteria involved adult patients of both sexes (aged 18 to 70 years) with arterial hypertension, undergoing drug treatment and regular follow-up during scheduled visits (the enrollment criterion was attending all consultations during the previous year). The exclusion criteria included impossibility or refusal to sign the informed consent form, participation in other research protocols, patients with end-stage chronic diseases, those with stage III hypertension<sup>8</sup> or refractory hypertension, obesity (BMI &gt; 30 kg/m<sup>2</sup>), heart arrhythmia, history of cardiocirculatory events in the last six months (acute myocardial infarction, cerebrovascular accident, transient ischemic accident), chronic kidney failure, decompensated heart failure, decompensated diabetes, other diseases that were considered by the investigator as possible compromising factors for the study, secondary hypertension and hormonal replacement therapy that had not been at a stable dose for at least six months.</p>
      <p>The anthropometric parameters were assessed as follows:</p>
      <p><italic>Body mass</italic> - Subjects wore light clothes and no shoes; a Toledo electronic scale with 100-g precision was used.</p>
      <p><italic>Height</italic> - Subjects were barefoot; a Filizola stadiometer with a 1-mm precision was used.</p>
      <p><italic>Body mass index (BMI)</italic> - Calculated using the formula established by QUETELET (BMI - weight in kg/height<sup>2</sup> in meters).</p>
      <p>The methods employed to measure BP were as follows:</p>
      <disp-quote>
        <p><italic>&#149; Casual BP measurement in the medical office</italic> - Carried out according to the techniques recommended by VI DBHA, 2010<sup>8</sup>. BP was measured with an automatic digital sphygmomanometer (OMRON 705 CP), with the patient in the sitting position, after a 10-minute rest, with the arm supported and at the level of the precordium. Two measurements were carried out in the morning, always by the same examiner, with a 2-minute interval between them; the mean value was considered for the analysis.</p>
        <p><italic>&#149; Self-measured BP</italic> - At the start of the study, the patients received a semi-automatic OMROM HEM 714 device for systematic BP measurement. It was established that the measurement should be carried out in the morning, between 8 AM and 10 AM, or in the evening, between 6 PM and 8 PM, in at least two days a week. Additional measurements could be taken at patients' discretion, but they were not used for the calculation of means. Patients were trained prior to the use of the device according to the recommendations by the VI DBHA and it was carried out by the authors of this protocol. Eight consecutive measurements (one month's worth) taken after the medical consultation were used to calculate the mean BP values.</p>
        <p><italic>&#149; ABPM</italic> - Carried out with the Spacelabs 9002 Monitor, with measurements being standardized every 15 minutes during the wakefulness period and every 20 minutes during sleep. The data were considered valid when the monitoring was carried out for a minimum period of 21 hours, with a minimum number of sixteen measurements during wakefulness and eight during sleep. Patients were advised to make a journal and note down all activities carried out during the period and time of drug administration<sup>9</sup>. When the ABPM was removed, the report was printed and a medical report was made. The latter was filed together with the printed report in the patient's file. All measurements obtained were considered for the calculation of 24-hour means; to calculate the means during wakefulness, measurements obtained between 7 AM and 11 PM were considered; to calculate the means during the sleep period, measurements obtained between 11 PM and 7 AM were considered.</p>
      </disp-quote>
      <p>The data were stored and structured using the MS Excel program. The statistical analysis was carried out using the SPSS (<italic>Statistical Package of Social Science</italic>) software for Windows release 15.0. Kolmogorov-Smirnov test was used to analyze whether the numerical variables had a normal distribution. The <italic>t</italic> test for paired samples was used to compare means, numerical variables and Pearson's correlation was used to assess the correlation between self-measured BP and ABPM and the casual BP measurement in the office.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>A total of 32 patients were assessed, of which 50.09% were females and the mean age was 59.7 (&#177; 11.2) years. BMI mean 26.04 (&#177; 3.3) kg/m<sup>2</sup>.</p>
      <p>The mean values of systolic (SBP) and diastolic blood pressure (DBP) found by self-measured BP were 134.00 (&#177; 15.71) mmHg and 79.32 (&#177; 12.38) mmHg, respectively. As for the casual measurement, mean SBP was 140.84 (&#177; 16.15) mmHg, and mean DBP was 85.00 (&#177; 9.68) mmHg. Mean BP values at ABPM during wakefulness were 130.47(&#177; 13.26) mmHg and 79.84 (&#177; 9.82) mmHg for SBP and DBP, respectively (<xref ref-type="table" rid="tab1-body2">Tables 1</xref> and <xref ref-type="table" rid="tab2-body2">2</xref>).</p>
      <table-wrap id="tab1-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gt01-en.jpg"/></table-wrap>
      <table-wrap id="tab2-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gt02-en.jpg"/></table-wrap>
      <p>When comparing BP means, significant differences were observed between ABPM and casual measurements, for both SBP (p = 0.031) and DBP (p = 0.003) (<xref ref-type="table" rid="tab1-body2">Table 1</xref>).</p>
      <p>When comparing SMBP with ABPM during wakefulness, no differences were observed between SBP and DBP means (p = 0.064 and p = 0.719) (<xref ref-type="table" rid="tab2-body2">Table 2</xref>).</p>
      <p>There was a significant correlation between SMBP and casual measurements for both SBP and DBP (p &lt; 0.017 and p &lt; 0.000, respectively), as well as between SMBP and ABPM during wakefulness (p &lt; 0.000 for SBP and DBP). However, the best correlation was found between values obtained by SMBP and ABPM during wakefulness, for both SBP and DBP (r = 0.755 and 0.753) in comparison to those obtained by SMBP and casual measurements for SBP and DBP, respectively (r = 0.419 e r = 0.609). No correlation was observed between SBP values obtained in the casual measurement and those obtained by ABPM during wakefulness (p = 0.227); there was a significant correlation only with the DBP in this case (p &lt; 0.000) (<xref ref-type="fig" rid="en_aop06811fig01-body2">Figures 1</xref>, <xref ref-type="fig" rid="en_aop06811fig02-body2">2</xref> and <xref ref-type="fig" rid="en_aop06811fig03-body2">3</xref>).</p>
      <p content-type="asset">
        <fig id="en_aop06811fig01-body2">
          <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf01-en.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="en_aop06811fig02-body2">
          <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf02-en.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="en_aop06811fig03-body2">
          <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf03-en.jpg"/></fig>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>Casual blood pressure measurement by healthcare professionals has been the mainstay of the diagnosis and follow-up of the hypertensive patient for more than one hundred years. However, it is necessary to face the limitations and weaknesses of this method, considering the large BP variability that occurs throughout the day, the effect of several interferences on BP values caused by diverse situations and the correlation of these facts to the small number of measurements that are performed when using this method<sup>15,16</sup>.</p>
      <p>A series of other factors can also interfere with isolated measurements obtained by healthcare professionals in the medical office and these can depend on the examiner, the patient or the device, resulting in situations that often do not represent the individual's actual BP levels<sup>17,18</sup>. In this context, the masked hypertension will not be diagnosed if methods that allow BP measurement outside the office environment are not used, and, consequently, these patients with increased cardiovascular risk will not be adequately treated<sup>19,20</sup>. On the other hand, and due to the same method limitation, patients with white-coat hypertension will receive unnecessary treatment<sup>21</sup>.</p>
      <p>Ambulatory blood pressure monitoring (ABPM) is a method that allows a higher degree of precision in patient diagnosis and follow-up<sup>4,14,15,17</sup>. However, the use of this methodology in all hypertensive patients would be too costly and unfeasible from the point of view of the public health system. The limitations described herein indicate the need for other methodologies that allow BP measurement outside the hospital or ambulatory environment that are low-cost and reliable and can supply BP values without the influence of the healthcare professional as observer. These are the characteristics of self-measured blood pressure (SMBP).</p>
      <p>The self-measured BP represented by the model adopted in the present study has yielded few publications in national and international journals. What is frequently found in the literature is a reference to the term SMBP (self-measured blood pressure or home-measured blood pressure) as the equivalent to home blood pressure monitoring, which includes advice on how to use the devices according to pre-established protocols . In this sample, the patients were advised to perform a minimum of two weekly BP measurements, but they were free to perform additional ones. Corroborating the methodology used in the present study, the guidelines of the European Society of Hypertension recently recommended that two weekly BP measurements with validated devices could be used for the long-term follow-up of hypertensive patients<sup>22</sup>.</p>
      <p>Our objective was not to analyze cardiovascular outcomes; we tested the hypothesis that the BP measurement carried out by the patient in the home environment, using validated devices with no pre-established protocols would have a better correlation and comparison with ABPM than the casual BP measurement, which was confirmed.</p>
      <p>The question regarding the reliability and reproducibility of SMBP has been previously tested, but with pre-established measurement protocols and satisfactory results for this type of analysis, even concerning the prediction of cardiovascular outcomes<sup>22-24</sup>.</p>
      <p>Our results show that BP values in SMBP are lower than those obtained by the casual measurement and closer to those obtained by ABPM during wakefulness. Moreover, SMBP has good correlation with both methodologies. These findings indicate good perspectives for this method in the follow-up of hypertensive patients, being capable of attenuating several measurement biases that occur when only the casual measurement is used and allowing a higher number of individuals to have access to BP monitoring<sup>25</sup>.</p>
      <p>Another publication demonstrated that SMBP, in addition to having a better correlation and comparison with ABPM than the casual measurement, is also a better predictor of left ventricular hypertrophy risk in hypertensive patients<sup>22</sup>, which supports its usefulness in the routine follow-up of these patients. Therefore, the perspective of using this method seems quite attractive and deserves to be further studied, with a great probability of having it incorporated as an alternative for the follow-up of the hypertensive patient.</p>
      <p>The superiority of ABPM and HBPM in comparison to casual BP measurement has been demonstrated<sup>15,25</sup> and guidelines have even recommended a more frequent use of these methods<sup>26</sup>. Recently, some studies recommended that BP measurements outside the ambulatory environment, carried out by the patients with validated devices should be increasingly more used, taking into account that this methodology shows advantages in the follow-up and treatment of arterial hypertension<sup>9,17,22,27-29</sup>.</p>
      <p>This recommendation can represent, in a near future, a change in the paradigm of blood pressure measurement and control, as patients would have active and more important roles regarding the awareness and follow-up of their BP levels, perhaps with a positive impact on adherence and BP control rates.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>These findings indicate the possibility of using SMBP as an alternative method to monitor BP in the hypertensive population, with better comparison and correlation with ABPM than the casual BP measurement.</p>
      <p>
        <bold>Study limitations</bold>
      </p>
      <p>The number of patients assessed in this study is small and other analyses with larger sample sizes are necessary. In spite of that fact, the statistical significance in both the comparison and correlation analyses leads us to believe that the conclusions of the present study are pointing toward the correct direction.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Comparaci&#243;n y correlaci&#243;n entre automedida, medida casual y monitorizaci&#243;n ambulatoria de la presi&#243;n arterial</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La medida casual de la presi&#243;n arterial (PA), por los profesionales de la salud est&#225; sujeta a una gran variabilidad, siendo necesario buscar nuevos m&#233;todos que puedan superar esa limitaci&#243;n. OBJETIVO: Comparar y evaluar la correlaci&#243;n entre los niveles de PA obtenidos por medio de la automedida de la presi&#243;n arterial (AMPA) con la medida casual y con la monitorizaci&#243;n ambulatoria de la presi&#243;n arterial (MAPA). M&#201;TODOS: Evaluamos hipertensos que realizaron las tres metodolog&#237;as de medida de la PA con un intervalo menor que 30 d&#237;as. Los promedios de las presiones fueron utilizados para la comparaci&#243;n y la correlaci&#243;n. Fueron usados los aparatos: OMRON 705 CP (medida casual), OMRON HEM 714 (AMPA) y SPACELABS 9002 (MAPA). RESULTADOS: Se evaluaron 32 pacientes, 50,09% mujeres, edad promedio 59,7(&#177; 11,2) a&#241;os, promedio del IMC 26,04 (&#177; 3,3) kg/m&#178;. Los valores promedios de presi&#243;n sist&#243;lica (PAS) y presi&#243;n diast&#243;lica (PAD) para la AMPA fueron de 134 (&#177; 15,71) mmHg y 79,32(&#177; 12,38) mmHg. En la medida casual los promedios de la PAS y PAD fueron, respectivamente, 140,84 (&#177; 16,15) mmHg y 85 (&#177; 9,68) mmHg. Los valores promedios de la MAPA en la vigilia fueron 130,47 (&#177; 13,26) mmHg y 79,84 (&#177; 9,82) mmHg para PAS y PAD, respectivamente. En el an&#225;lisis comparativo, la AMPA tuvo valores similares a los de la MAPA (p &gt; 0,05) y diferentes de la medida casual (p &lt; 0,05). En el an&#225;lisis de correlaci&#243;n la AMPA fue superior a la medida casual, considerando la MAPA como el est&#225;ndar de referencia en las medidas tensionales. CONCLUSI&#211;N: La AMPA present&#243; una mejor comparaci&#243;n con la MAPA que la medida casual y tambi&#233;n se correlacion&#243; mejor con aquella, especialmente para la presi&#243;n diast&#243;lica, debiendo ser considerada como una alternativa con bajo coste para el seguimiento del paciente hipertenso.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Hipertensi&#243;n</kwd>
        <kwd>presi&#243;n arterial</kwd>
        <kwd>monitorizaci&#243;n ambulatoria de la presi&#243;n arterial</kwd>
        <kwd>autocuidado</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ESPECIAL</bold>
      </p>
      <p>
        <fn id="nota_1-body3">
          <label>
            <bold>Comparaci&#243;n y correlaci&#243;n entre automedida, medida casual y monitorizaci&#243;n ambulatoria de la presi&#243;n arterial</bold>
          </label>
          <p>
            <bold>Weimar Kunz Sebba Barroso de Souza; Paulo C&#233;sar Brand&#227;o Veiga Jardim; Ludmila Brito Porto; Fabr&#237;cio Alves Ara&#250;jo; Ana Lu&#237;za Lima Sousa; Cl&#225;udia Maria Salgado</bold>
          </p>
        </fn>
      </p>
      <p>Liga de Hipertens&#227;o Arterial, Faculdade de Medicina, Universidade Federal de Goi&#225;s, Goi&#226;nia, GO - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> La medida casual de la presi&#243;n arterial (PA), por los profesionales de la salud est&#225; sujeta a una gran variabilidad, siendo necesario buscar nuevos m&#233;todos que puedan superar esa limitaci&#243;n.</p>
      <p><bold>OBJETIVO:</bold> Comparar y evaluar la correlaci&#243;n entre los niveles de PA obtenidos por medio de la automedida de la presi&#243;n arterial (AMPA) con la medida casual y con la monitorizaci&#243;n ambulatoria de la presi&#243;n arterial (MAPA).</p>
      <p><bold>M&#201;TODOS:</bold> Evaluamos hipertensos que realizaron las tres metodolog&#237;as de medida de la PA con un intervalo menor que 30 d&#237;as. Los promedios de las presiones fueron utilizados para la comparaci&#243;n y la correlaci&#243;n. Fueron usados los aparatos: OMRON 705 CP (medida casual), OMRON HEM 714 (AMPA) y SPACELABS 9002 (MAPA).</p>
      <p><bold>RESULTADOS:</bold> Se evaluaron 32 pacientes, 50,09% mujeres, edad promedio 59,7(&#177; 11,2) a&#241;os, promedio del IMC 26,04 (&#177; 3,3) kg/m<sup>2</sup>. Los valores promedios de presi&#243;n sist&#243;lica (PAS) y presi&#243;n diast&#243;lica (PAD) para la AMPA fueron de 134 (&#177; 15,71) mmHg y 79,32(&#177; 12,38) mmHg. En la medida casual los promedios de la PAS y PAD fueron, respectivamente, 140,84 (&#177; 16,15) mmHg y 85 (&#177; 9,68) mmHg. Los valores promedios de la MAPA en la vigilia fueron 130,47 (&#177; 13,26) mmHg y 79,84 (&#177; 9,82) mmHg para PAS y PAD, respectivamente. En el an&#225;lisis comparativo, la AMPA tuvo valores similares a los de la MAPA (p &gt; 0,05) y diferentes de la medida casual (p &lt; 0,05). En el an&#225;lisis de correlaci&#243;n la AMPA fue superior a la medida casual, considerando la MAPA como el est&#225;ndar de referencia en las medidas tensionales.</p>
      <p><bold>CONCLUSI&#211;N:</bold> La AMPA present&#243; una mejor comparaci&#243;n con la MAPA que la medida casual y tambi&#233;n se correlacion&#243; mejor con aquella, especialmente para la presi&#243;n diast&#243;lica, debiendo ser considerada como una alternativa con bajo coste para el seguimiento del paciente hipertenso.</p>
      <p><bold>Palabras clave:</bold> Hipertensi&#243;n, presi&#243;n arterial, monitorizaci&#243;n ambulatoria de la presi&#243;n arterial, autocuidado.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La hipertensi&#243;n arterial es un importante factor de riesgo para las enfermedades cardiovasculares y contribuye, directa e indirectamente, para la elevada morbimortalidad, tanto en los pa&#237;ses desarrollados como en los pa&#237;ses en desarrollo<sup>1,2</sup>. En ese contexto, la determinaci&#243;n precisa de los niveles pres&#243;ricos es fundamental para la estratificaci&#243;n del riesgo y para la definici&#243;n de la estrategia terap&#233;utica adecuada, siendo importante buscar opciones para la gran variabilidad de la presi&#243;n arterial frente a los factores estresantes, como por ejemplo, durante una consulta con el profesional de salud<sup>3,4</sup>.</p>
      <p>La medida indirecta de la PA en una consulta (medida casual), se considera el procedimiento est&#225;ndar para el diagn&#243;stico y el seguimiento de pacientes hipertensos con valor predictivo para la morbilidad y la mortalidad cardiovascular. Sin embargo, si se le compara con los m&#233;todos de monitorizaci&#243;n de la PA, es inferior. La explicaci&#243;n para ese hecho radica en las limitaciones de la medida casual que van desde la influencia del observador (sesgos de comprobaci&#243;n, efecto de la bata blanca), hasta el ambiente en donde se realiza y el n&#250;mero reducido de lecturas con una baja reproductibilidad a largo plazo<sup>5-8</sup>.</p>
      <p>Entre los m&#233;todos de monitorizaci&#243;n, se destaca la monitorizaci&#243;n ambulatoria de la presi&#243;n arterial (MAPA), como un est&#225;ndar de referencia, permitiendo la evaluaci&#243;n de la PA durante las actividades habituales en la vigilia y durante el sue&#241;o, y posibilitando as&#237; la realizaci&#243;n de un mayor n&#250;mero de medidas, y el conocimiento de la variabilidad y del descenso de la PA durante el sue&#241;o. La monitorizaci&#243;n residencial de la presi&#243;n arterial (MRPA), es otro m&#233;todo reconocido y se caracteriza por contar con protocolos bastante establecidos (cierto n&#250;mero de medidas de la PA por la ma&#241;ana y por la noche), y tiene la ventaja de poder hacer un mayor n&#250;mero de mediciones fuera del ambiente de la consulta y con un buen nivel de aceptaci&#243;n por parte del paciente<sup>9</sup>. Algunos estudios indican que los promedios de la presi&#243;n arterial obtenidos por MAPA y MRPA son menores que los obtenidos por medio de la medida casual, poseen un mayor nivel de exactitud en el diagn&#243;stico y una mejor predicci&#243;n de riesgo cardiovascular, sin embargo, son m&#233;todos caros y poco accesibles a nuestros hipertensos<sup>10-12</sup>.</p>
      <p>Tambi&#233;n se discute una tercera metodolog&#237;a de monitorizaci&#243;n, que es la automedida de la presi&#243;n arterial (AMPA), y que es el objetivo de este estudio. Sobre ese m&#233;todo, existen pocas publicaciones hasta el momento. Su caracter&#237;stica es la falta de protocolos preestablecidos, el propio paciente realiza las mediciones en su domicilio aleatoriamente y en aparatos digitales autom&#225;ticos o semiautom&#225;ticos validados. Su ventaja es el bajo coste, la facilidad de manejo y la posibilidad de evitar errores de lectura<sup>13,14</sup>. Se justifica as&#237; la realizaci&#243;n de este estudio para evaluar la PA obtenida por la AMPA, comparada con la medida casual y MAPA, ya que ese m&#233;todo podr&#225; convertirse en un futuro pr&#243;ximo, en una alternativa de bajo coste y muy viable para la monitorizaci&#243;n del hipertenso.</p>
      <p>
        <bold>Objetivos</bold>
      </p>
      <p>Comparar y correlacionar los niveles de presi&#243;n arterial obtenidos por medio de AMPA con la medida casual en una consulta y con la MAPA.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>El proyecto de investigaci&#243;n n&#250;mero 144/07 fue evaluado y aprobado por el Comit&#233; de &#201;tica en Investigaci&#243;n M&#233;dica Humana y Animal del <italic>Hospital das Cl&#237;nicas </italic>de la <italic>Faculdade de Medicina da Universidade Federal de Goi&#225;s </italic>(UFG). Los participantes fueron informados sobre los procedimientos del estudio y firmaron el T&#233;rmino de Consentimiento Informado.</p>
      <p>Se trata de un estudio prospectivo conun muestreo constituido por pacientes en seguimiento en la Liga de Hipertensi&#243;n Arterial, e invitados a realizar la medici&#243;n casual, MAPA y AMPA, con un intervalo menor a 30 d&#237;as entre los m&#233;todos (n = 32).</p>
      <p>El criterio de inclusi&#243;n seleccion&#243; a adultos de ambos sexos (mayores de 18 y menores de 70 a&#241;os), portadores de hipertensi&#243;n arterial bajo tratamiento medicamentoso, en seguimiento regular a las consultas programadas (el criterio de adhesi&#243;n fue la comparecencia a todas las consultas en el a&#241;o anterior). Los criterios de exclusi&#243;n contemplaron la imposibilidad o la negaci&#243;n para firmar el t&#233;rmino de consentimiento, la participaci&#243;n en otros protocolos de investigaci&#243;n, portadores de enfermedades cr&#243;nicas en estadios terminales, portadores de hipertensi&#243;n estadio III<sup>8 </sup>o hipertensi&#243;n resistente, obesidad (IMC &gt; 30 kg/m<sup>2</sup>), arritmia card&#237;aca, historial de eventos cardiocirculatorios en los &#250;ltimos seis meses (infarto agudo del miocardio, accidente cerebrovascular, accidente isqu&#233;mico transitorio), insuficiencia renal cr&#243;nica, insuficiencia card&#237;aca descompensada, diabetes descompensada, y otras enfermedades que, a juicio del investigador, pudiesen comprometer el estudio, como la hipertensi&#243;n secundaria y la terapia de reposici&#243;n hormonal que no estuviesen en una dosis estable por lo menos durante seis meses.</p>
      <p>Los par&#225;metros antropom&#233;tricos se evaluaron como exponemos a continuaci&#243;n:</p>
      <p><italic>Masa corporal </italic>-Individuos vestidos con ropas ligeras y sin zapatos, con utilizaci&#243;n de una b&#225;scula electr&#243;nica de la marca Toledo con una precisi&#243;n de 100 g.</p>
      <p><italic>Altura </italic>- Individuos descalzos utilizando estadi&#243;metro de la marca Filizola con una precisi&#243;n de un mil&#237;metro.</p>
      <p><italic>&#205;ndice de masa corporal (IMC) </italic>- Mediante la f&#243;rmula establecida por QUETELET (IMC = peso en kg/altura<sup>2 </sup>en metro).</p>
      <p>Las metodolog&#237;as usadas en la medida de la presi&#243;n arterial fueron:</p>
      <disp-quote>
        <p>&#149; <italic>Medida casual en consulta </italic>- Realizada a tono con las t&#233;cnicas recomendadas por las VI DBHA, 2010<sup>8</sup>. La PA se calcul&#243; con el esfigmoman&#243;metro autom&#225;tico digital (OMRON 705 CP), con el paciente en la posici&#243;n sentada, despu&#233;s de 10 minutos en reposo, y con el brazo apoyado y a la altura del precordio. Se hicieron dos mediciones en el per&#237;odo de la ma&#241;ana, siempre hechas por el mismo observador, con un intervalo de dos minutos entre ellas y considerando el promedio a los efectos del an&#225;lisis.</p>
        <p>&#149; <italic>Automedida </italic>- Al iniciarse el estudio, los pacientes recibieron un aparato semiautom&#225;tico HEM 714 de la marca OMRON para la automedida sistem&#225;tica de la presi&#243;n arterial, siendo establecido que la medida deber&#237;a ser hecha en el per&#237;odo matutino entre las 8h y las 10h, o en el per&#237;odo vespertino entre las 18h y las 20h, durante como m&#237;nimo, dos d&#237;as por semana. Medidas adicionales pudieron ser realizadas a juicio de los pacientes, pero no fueron utilizadas para el c&#225;lculo del promedio. El entrenamiento para el uso del aparato de acuerdo con las orientaciones de la VI DBHA, fue realizado por los autores de este protocolo. Para el c&#225;lculo del promedio consideramos ocho medidas consecutivas (durante un mes), a la consulta m&#233;dica del paciente.</p>
        <p>&#149; <italic>MAPA </italic>- Realizada con el Monitor Spacelabs 9002, siendo estandarizadas medidas a cada 15 minutos en el per&#237;odo de vigilia, y a cada 20 minutos en el per&#237;odo de sue&#241;o. Los datos fueron considerados v&#225;lidos cuando la monitorizaci&#243;n se dio por un per&#237;odo m&#237;nimo de 21h con un n&#250;mero m&#237;nimo de 16 medidas en la vigilia y de ocho medidas durante el sue&#241;o. El paciente fue orientado a redactar un diario y a anotar, el d&#237;a del examen, todas las actividades realizadas en el per&#237;odo y los horarios en que tomaba la medicaci&#243;n<sup>9</sup>. Al retirar la MAPA, se imprimi&#243; el informe y se envi&#243; para el parecer m&#233;dico. Se archiv&#243; junto con el informe impreso en la historia cl&#237;nica del paciente. Para el c&#225;lculo de los promedios de las 24 horas, fueron consideradas todas las medidas obtenidas; para el c&#225;lculo de los promedios de vigilia fueron consideradas las medidas realizadas en el per&#237;odo de las 7h a las 23h, y para el c&#225;lculo de los promedios de sue&#241;o se tuvieron en cuenta las medidas obtenidas de las 23h a las 7h.</p>
      </disp-quote>
      <p>Los datos se almacenaron y se estructuraron en el programa Excel Microsoft. El an&#225;lisis estad&#237;stico fue realizado por medio del <italic>software </italic>SPSS (<italic>Statistical Package of Social Science</italic>), para Windows versi&#243;n 15.0. El test de Kolmogorov-Smirnov fue utilizado para analizar si las variables num&#233;ricas ten&#237;an una distribuci&#243;n normal. El test <italic>t </italic>para la muestra pareada fue utilizado para comparar los promedios, las variables num&#233;ricas y la correlaci&#243;n de Pearson, para evaluar la correlaci&#243;n entre la PA de la automedida con la MAPA y la medida casual de la consulta.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Fueron evaluados 32 pacientes: 50,09% eran del sexo femenino y el promedio de edad fue de 59,7 (&#177; 11,2) a&#241;os. El promedio del IMC fue de 26,04 (&#177; 3,3) kg/m<sup>2</sup>.</p>
      <p>Los valores promedios de presi&#243;n sist&#243;lica (PAS) y de presi&#243;n diast&#243;lica (PAD), encontrados por la automedida fueron de 134,00 (&#177;15,71) mmHg y 79,32 (&#177; 12,38) mmHg, respectivamente. En la medida casual, el promedio de la PAS fue 140,84 (&#177; 16,15) mmHg, y el de la PAD fue 85,00 (&#177; 9,68) mmHg. El promedio de las medidas por la MAPA en la vigilia fue de 130,47 (&#177; 13,26) mmHg y 79,84 (&#177; 9,82) mmHg para PAS y PAD respectivamente (<xref ref-type="table" rid="tab1-body3">tablas 1</xref> y <xref ref-type="table" rid="tab2-body3">2</xref>).</p>
      <table-wrap id="tab1-body3">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gt01-es.jpg"/></table-wrap>
      <table-wrap id="tab2-body3">
        <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gt02-es.jpg"/></table-wrap>
      <p>Al realizar la comparaci&#243;n entre los promedios de las presiones encontramos diferencias significativas en los promedios pres&#243;ricos entre AMPA y la medida casual, tanto para la PAS (p = 0,031) como para la PAD (p = 0,003) (<xref ref-type="table" rid="tab1-body3">tab. 1</xref>). Pero en la comparaci&#243;n de la AMPA con la MAPA en la vigilia no observamos una diferencia entre los promedios de las PAS y PAD (p = 0,064 y p = 0,719) (<xref ref-type="table" rid="tab2-body3">tab. 2</xref>).</p>
      <p>Encontramos una correlaci&#243;n significativa entre la AMPA y la PA casual tanto para PAS como para PAD (p &lt; 0,017 y p &lt; 0,000, respectivamente), como tambi&#233;n entre la AMPA y la MAPA de vigilia (p &lt; 0,000 para PAS y PAD). Sin embargo, la correlaci&#243;n fue mejor entre los valores obtenidos por la AMPA con los de la MAPA de vigilia tanto para PAS y PAD (r = 0,755 y 0,753) en comparaci&#243;n con los observados en las medidas por la AMPA y medida casual para PAS y PAD, respectivamente (r = 0,419 y r = 0,609). No se observ&#243; ninguna correlaci&#243;n entre los valores de la PAS obtenidos por la medida casual con los de la MAPA durante la vigilia (p = 0,227), habiendo una correlaci&#243;n significativa apenas con la PAD en ese caso (p &lt; 0,000) (<xref ref-type="fig" rid="es_a09fig01-body3">fig. 1</xref>, <xref ref-type="fig" rid="es_a09fig02-body3">2</xref> y <xref ref-type="fig" rid="es_a09fig03-body3">3</xref>).</p>
      <p content-type="asset">
        <fig id="es_a09fig01-body3">
          <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf01-es.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="es_a09fig02-body3">
          <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf02-es.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="es_a09fig03-body3">
          <graphic xlink:href="1678-4170-abc-97-02-0148-00076-gf03-es.jpg"/></fig>
      </p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>La medida casual de la presi&#243;n arterial ha sido el pilar del diagn&#243;stico y del seguimiento del paciente hipertenso hace m&#225;s de cien a&#241;os. Sin embargo, es preciso hacerle frente a las limitaciones y a las fragilidades de esa metodolog&#237;a, teniendo en cuenta la gran variaci&#243;n que ocurre en la PA a lo largo del d&#237;a, las innumerables interferencias que diversas situaciones provocan en sus valores y correlacionar esos hechos con el peque&#241;o n&#250;mero de medidas que son realizadas por ese m&#233;todo<sup>15,16</sup>.</p>
      <p>Una serie de otros factores tambi&#233;n interfieren en las medidas aisladas en las consultas de los m&#233;dicos, y esos factores pueden depender del operador, del paciente o del aparato, trayendo como consecuencia, situaciones que muchas veces no est&#225;n a tono con los niveles reales de la presi&#243;n arterial del individuo<sup>17,18</sup>. En ese sentido, la hipertensi&#243;n disimulada no ser&#225; diagnosticada si no usamos m&#233;todos que permitan la medida de la PA fuera del ambiente de la consulta, y esos pacientes que tienen un riesgo cardiovascular mayor no ser&#225;n tratados de manera adecuada<sup>19,20</sup>. En otro extremo de esta l&#237;nea de pensamiento, y por la misma limitaci&#243;n del m&#233;todo, encontraremos a los portadores de hipertensi&#243;n del s&#237;ndrome de la bata blanca, que recibir&#225;n medicamentos sin necesidad<sup>21</sup>.</p>
      <p>La MAPA es un m&#233;todo que permite una mayor precisi&#243;n en el diagn&#243;stico y en el seguimiento de los pacientes<sup>4,14,15,17</sup>, pero la realizaci&#243;n de esa metodolog&#237;a en todos los hipertensos ser&#237;a muy cara y muy poco viable desde el punto de vista de la salud p&#250;blica. Las limitaciones aqu&#237; descritas indican la necesidad de poder contar con otras metodolog&#237;as que permitan medir la presi&#243;n arterial fuera del ambiente hospitalario o ambulatorial, con un bajo coste y que sean confiables, y tambi&#233;n que nos suministren los valores de la PA sin la influencia del m&#233;dico como observador. Esas caracter&#237;sticas las respeta la AMPA.</p>
      <p>La automedida de la presi&#243;n arterial en el modelo adoptado en este estudio tiene pocos art&#237;culos en publicaciones nacionales e internacionales. A menudo, lo que se ve en la literatura, es la referencia al t&#233;rmino AMPA (<italic>self measured blood pressure o home blood pressure</italic>), como equivalente a la monitorizaci&#243;n residencial de la presi&#243;n arterial con orientaciones para el uso de los aparatos de acuerdo con los protocolos preestablecidos. En nuestra muestra, a los pacientes se les orient&#243; que hiciesen un m&#237;nimo de dos medidas por semana de la PA, d&#225;ndoles la libertad de que otras medidas se realizasen tambi&#233;n. Corroborando la metodolog&#237;a adoptada en este estudio, la Sociedad Europea de Hipertensi&#243;n, recomend&#243; recientemente en sus directrices que, para el seguimiento a largo plazo de los pacientes hipertensos, dos medidas semanales con los aparatos validados pueden ser usadas<sup>22</sup>.</p>
      <p>No fue nuestro objetivo analizar los desenlaces cardiovasculares, lo que comprobamos fue la hip&#243;tesis de que la medida de la PA por el paciente, en un ambiente hogare&#241;o, con aparatos validados y sin protocolos preestablecidos, tendr&#237;a una mejor correlaci&#243;n y una mejor comparaci&#243;n con la MAPA que la medida casual, hip&#243;tesis que se confirm&#243;. La cuesti&#243;n sobre la confiabilidad y la reproductibilidad de la AMPA ya fue testada anteriormente, pero con protocolos de medidas preestablecidas y con resultados satisfactorios para ese tipo de an&#225;lisis, incluso en la predicci&#243;n de los desenlaces cardiovasculares<sup>22-24 </sup>.</p>
      <p>Nuestros resultados muestran que los valores de presi&#243;n arterial en la AMPA son m&#225;s bajos que los obtenidos por la medida casual, y m&#225;s coincidentes con los encontrados en la MAPA en la vigilia. Adem&#225;s, la AMPA presenta una buena correlaci&#243;n con las dos metodolog&#237;as. Esos hallazgos nos indican las buenas perspectivas de ese m&#233;todo en el seguimiento de los pacientes hipertensos, y puede atenuar diversas desviaciones de las medidas que surgen cuando utilizamos solamente la medida casual de la presi&#243;n arterial, permitiendo que un n&#250;mero mayor de individuos pueda tener acceso a la monitorizaci&#243;n de su PA<sup>25</sup>.</p>
      <p>Otra publicaci&#243;n demostr&#243; que la AMPA, adem&#225;s de compararse y correlacionarse mejor con la MAPA que con la medida casual, tambi&#233;n es una mejor predictora de riesgo para la hipertrofia ventricular izquierda en hipertensos<sup>22</sup>, lo que refuerza su utilidad en la rutina de seguimiento a esos pacientes. Por tanto, la perspectiva de la utilizaci&#243;n de ese m&#233;todo nos parece bastante atractiva, y merece m&#225;s estudios con grandes posibilidades de ser incorporada como una opci&#243;n m&#225;s para el seguimiento del paciente hipertenso.</p>
      <p>La superioridad de las MAPA y MRPA en la comparaci&#243;n con la medida casual de la PA ya fue demostrada<sup>15,25</sup>, habiendo incluso, la recomendaci&#243;n en las directrices para la utilizaci&#243;n m&#225;s com&#250;n de esos m&#233;todos<sup>26</sup>. Recientemente, algunos estudios incluyeron recomendaciones para que la medida de la PA fuera del ambiente ambulatorial, realizada por el paciente y con aparatos validados, sea cada vez m&#225;s utilizada, entendiendo que existe tambi&#233;n en esa metodolog&#237;a, ventajas en el seguimiento y en el tratamiento de la hipertensi&#243;n arterial<sup>9,17,22,27-29</sup>.</p>
      <p>Esa orientaci&#243;n puede representar, en un futuro muy cercano, un cambio en el paradigma de la medida y del control de la presi&#243;n arterial, porque el paciente pasar&#237;a a tener un rol activo y m&#225;s importante en el conocimiento y en el seguimiento de sus niveles pres&#243;ricos, y qui&#233;n sabe eso interfiera positivamente en las tasas de adhesi&#243;n y control de la PA.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Esos hallazgos indican la posibilidad de la utilizaci&#243;n de la AMPA como un m&#233;todo alternativo de monitorizaci&#243;n de la presi&#243;n en la poblaci&#243;n hipertensa, con una mejor comparaci&#243;n y correlaci&#243;n con la MAPA que la medida casual.</p>
      <p>
        <bold>Limitaciones del estudio</bold>
      </p>
      <p>El n&#250;mero de pacientes evaluados en este estudio es peque&#241;o y por tanto, se hacen necesarios otros an&#225;lisis con un nivel de muestreo mayor. Pese a eso, la significancia estad&#237;stica tanto en el an&#225;lisis de comparaci&#243;n como en la correlaci&#243;n, nos lleva a pensar que las conclusiones de este trabajo van por el camino correcto.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuve fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de tesis de Doctorado de Weimar Kunz Sebba Barroso Souza, por <italic>Universidade Federal de Goi&#225;s</italic>.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
